Stefania Pittaluga
Researcher Next ID · RN-022485
Researcher · Medicine
Bethesda, Malaysia
- Works count
- 803
- Citation count
- 46,712
- H-index
- 116
- i10-index
- 381
Research interests
Publications
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
Nature · 2022 · https://doi.org/10.1038/s41586-022-05542-y
SARS-CoV-2 infection of the oral cavity and saliva
Nature Medicine · 2021 · 10.1038/s41591-021-01296-8
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series
EClinicalMedicine · 2020 · 10.1016/j.eclinm.2020.100434
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1801445
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
Nature · 2018 · 10.1038/s41586-018-0290-0
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia
Blood · 2017 · 10.1182/blood-2016-06-719294
Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI
eLife · 2017 · 10.7554/elife.29738
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Cancer Cell · 2017 · 10.1016/j.ccell.2017.04.012
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)70106-3
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Nature Medicine · 2015 · https://doi.org/10.1038/nm.3884
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)71182-9
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Science · 2014 · https://doi.org/10.1126/science.1255904
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
Clinical Cancer Research · 2013 · 10.1158/1078-0432.ccr-12-2422
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
New England Journal of Medicine · 2013 · 10.1056/nejmoa1214561
Low-Intensity Therapy in Adults with Burkitt's Lymphoma
New England Journal of Medicine · 2013 · 10.1056/nejmoa1308392
Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
Nature Immunology · 2013 · 10.1038/ni.2771
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Nature · 2012 · https://doi.org/10.1038/nature11378
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Blood · 2011 · 10.1182/blood-2011-05-356352
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Blood · 2010 · 10.1182/blood-2010-05-284984
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
PLoS Pathogens · 2010 · 10.1371/journal.ppat.1001052
EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression
The American Journal of Surgical Pathology · 2010 · 10.1097/pas.0b013e3181cf8622
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
Blood · 2009 · 10.1182/blood-2009-01-199679
Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities
The American Journal of Surgical Pathology · 2004 · 10.1097/01.pas.0000126781.87158.e3
Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology
Blood · 2003 · 10.1182/blood-2002-11-3589
Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1
Blood · 2002 · 10.1182/blood.v99.8.2703
Current projects
No projects listed.